Project Number 1R43AG071040-01 Agency/Funding Organization NIA Funding Year 2020 View Full Project Details for Direct activators of protein phosphatase 2A (PP2A) as novel Alzheimer's Disease (AD) therapeutics Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) r. Multi-target Researcher and Organization Principal Investigator OHLMEYER, MICHAEL Principal Investigator First Name MICHAEL Principal Investigator Last Name OHLMEYER Awardee State New Jersey Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-19-316: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) FY Overall Cost $447,795 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
